Company Insider Tape

Iovance Biotherapeutics Inc insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol IOVA Latest filing 16 Jun 2026

Company Read

Net disposal

IOVA has 32 stored insider filings. Acquisitions account for 43.8% of classified filings and disposals account for 56.2%. The largest stored filing is $70.1K from VOGT, FREDERICK G.

Latest filing 16 Jun 2026most recent stored row
Largest filing $70.1Kreported transaction value
Total filings 32stored transaction rows
Acquisition value $014 acquisitions
Disposal value $202.4K18 disposals
Net value $-202.4Kacquisitions minus disposals

Filing cadence

Last 12 active months
May 2026 3
Jun 2026 29

Acquisitions 43.8% · Disposals 56.2%

May 2026 $9.0K
Jun 2026 $193.4K

Executive concentration

By filing count
PURI, RAJ K. Chief Regulatory Officer · 7 filings
VOGT, FREDERICK G Director, Interim CEO & General Counsel · 6 filings
BILINSKY, IGOR Chief Operating Officer · 6 filings
GRAF, FINCKENSTEIN FRIEDRICH Chief Medical Officer · 6 filings
KIRBY, DANIEL GORDON Chief Commercial Officer · 3 filings
MAYNARD, RYAN D Director · 1 filings
DUKES, IAIN D. Director · 1 filings
COUNTOURIOTIS, ATHENA Director · 1 filings

Market Context

IOVA weekly market snapshot

Week 24 Jul 2026
Latest close 4.99 USDstored weekly close
1-week move -0.2%latest weekly bar
13-week move +17.4%medium-term context
Relative Strength 50.3Sharemaestro indicator
Fair value gap -15.7%price vs fair value
Trend signal 1smoothed trend state

Transaction History

Latest insider filings for IOVA

Showing 31-32 of 32
Date 11 May 2026
Insider KIRBY, DANIEL GORDONChief Commercial Officer
Side Disposal
Shares 10000
Price 0.00
Value 0
Security Restricted Stock Units
Date 11 May 2026
Insider KIRBY, DANIEL GORDONChief Commercial Officer
Side Acquisition
Shares 10000
Price 0.00
Value 0
Security Common Stock